A comparative clinical study of PF-06439535, a candidate bevacizumab biosimilar, and reference bevacizumab, in patients with advanced non-squamous non-small cell lung cancer von Socinski, Mark A., Von Pawel, Joachim, Kasahara, Kazuo, Bondarenko, Igor, Syrigos, Konstantinos, Vladimirov, Vladimir Ivanovich, Bryl, Maciej, Zereu, Manuela, Bair, A H., Hilton, Fiona, Liau, Katherine Faye, Herbst, Roy S.

Volltext